Læknablaðið - 15.09.1999, Síða 22
690
LÆKNABLAÐIÐ 1999; 85
Þakkir
Höfundar vilja þakka hjúkrunarfræðingum
þeim er hjálpuðu til við rannsóknina fyrir hlýj-
ar móttökur og ómetanlega aðstoð við söfnun
gagna.
HEIMILDIR
1. Daglegt líf á hjúkrunarheimili: Heilsufar og hjúkrunarþörf
íbúa á öldrunarstofnunum 1994. Reykjavík: Heilbrigðis- og
tryggingamálaráðuneytið 1995.
2. Jóhannesdóttir GB, Jónsson PV. Vistunarmatið. Lækna-
blaðið 1995;81:233-41.
3. Avom J, Gurwitz JH. Drug use in the nursing home. Ann Int
Med 1995; 123: 195-204.
4. Spore D, Mor V, Hiris J, Larrat P, Hawes C. Psychotropic
drug use among older residents of board and care facilities.
JAmGerSoc 1995; 43: 1403-9.
5. Snowden S. Mental health in nursing homes. Drugs Ageing
1993; 3: 122-30.
6. Philpot M, Puranik A. Psychotropic dmgs, aging and com-
munity care. Dmgs Ageing 1994; 5: 235-41.
7. Zalzman C. Pharmacokinetics of psychotropic drugs and the
ageing process. In: Salzman C, ed. Clinical geriatric
psychopharmacology. New York: McGraw Hill 1984: 32-42.
8. Pollock PG, Mulsant BH, Sweet RA, Rosen J, Altieri LP,
Perel JM. Prosepctive cytochrome P450 phenotyping for
neuroleptic treatment in dementia. Psychopharmacol Bull
1995;31:327-31.
9. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks
J, Beck JC, et al. Explicit criteria for determining inappro-
priate medication use in nursing home residents. Arch Int
Med 1991; 151: 1825-32.
10. Beers MH, Ouslander JG, Fingold SF, Morgenstem H, Reub-
en DB, Rogers W, et al. Inappropriate medication prescribing
in skilled-nursing facilities. Ann Int Med 1982; 117: 684-9.
11. Liv pá plejehjem: En profil af köbenhavnske plejehjemsbe-
boere 1992/93. Köbenhavn: Köbenhavns sundhedsdirekto-
rat 1994.
12. Microsoft Excel users guide, version 5.0. Ireland 1993.
13. Burns BJ, Larson DB, Goldstrom ID, Johnsson WE, Taube
CA. Mental disorders among nursing home patients: pre-
liminary findings from the national nursing home survey
protest. Int J Ger Psych 1988; 3: 27-35.
14. Nolan L, O'Malley K. The need for a more rational ap-
proach to drug prescribing for elderly people in nursing
homes. Age Ageing 1989; 18:52-66.
15. Clarke MG, Williams AJ, Jones PA. A psychogeriatric
survey of old peoples homes. BrMedJ 1981; 283: 1307-10.
16. Gilleard CJ, Morgan K, Wade BE. Pattems of neuroleptic
use among the institutionalised elderly. Acta Psych Scand
1983;68:419-25.
17. Heston LL, Garrard J, Makris L, Kane RL, Cooper S, Dun-
ham T. et al. Inadequate treatment of depressed nursing
home elderly. J Am Ger Soc 1992; 40: 1117-22.
18. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Fol-
sten MF. Depression and mortality in nursing homes.
JAMA 1991; 265: 993-6.
19. Hyer L, Blazer DG. Depression in long term care facilities.
In: Blazer DG, ed. Depression in late life. St. Louis: CV
Mosby 1982: 268.
20. Borson S, Liptzin B, Nininger J, Rabins P. Psychiatry and
the nursing home. Am J Psychiatry 1987; 144: 1412-8.
21. Willcox SM, Himmelstein DU, Woolhandler S. Inappro-
priate drug prescribing for the community dwelling elderly.
JAMA 1994; 272: 292-6.
22. ZoégaT. Ný þunglyndislyf. Mixtúra 1996; 10(1): 20-1.
23. Zalzman C. Overview. In: Salzman C, ed. Clinical geriatric
psychopharmacology. New York: McGraw Hill 1984: 3-13.
24. Ray WA, Griffin, MR, Downey W. Benzodiazepines of long
and short elimination half-life and the risk of hip fracture.
JAMA 1989; 262: 3303-7.
25. Koski K, Luukinen H, Laippala P, Kivela SL. Physiological
factors and medications as predictors of injurious falls by
elderly people: a prospective population based study. Age
Ageing 1996; 25:29-38.
26. Cumming RG, Miller JP. Kelsey JL, Davis P, Arfken CL,
Birge SJ, et al. Medications and multiple falls in elderly
people: The St. Louis OASIS study. Age Ageing 1991; 20:
455-61.
27. Regenstein ZR. Treatment of insomnia in the elderly. In:
Zalzman C, ed. Clinical geriatric psychopharmacology.
New York: McGraw Hill 1984: 149-66.